Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VALIDATE-SWEDEHEART: Bivalirudin versus heparin in myocardial infarction patients undergoing PCI
2012-005260-10Phase 4Completed
- Sponsor
- Uppsala Clinical Research Center
- Start
- Dec 2012
- Modality
- Small Molecules, Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Phase 4, randomised trial of bivalirudin and heparin in myocardial infarction (MI) and Non-ST-segment elevation myocardial infarction (NSTEMI) (2 arms), sponsored by Uppsala Clinical Research Center. Primary endpoints: Primary composite endpoint at 180 days and Composite ischemic and bleeding endpoint. Started Dec 2012; status: completed.
02
Drugs
bivalirudinheparin
03
Conditions
myocardial infarction (MI)Non-ST-segment elevation myocardial infarction (NSTEMI)
Beyond the preview
Go deeper on 2012-005260-10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-005260-10.